More recently, DPr1 deletion or blockade with an antagonist, asapiprant, or the deletion of an upstream biosynthetic enzyme–the phospholipase PLA2G2D–protected middle-aged mice against lethal infection with SARS-CoV-2 (Zhao et al., 2011). This evidence concerns the gene DACT1 and infection.